Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by tobacco smoke
- 1 March 1990
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 29 (3) , 311-314
- https://doi.org/10.1016/0028-3908(90)90019-n
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- An improved fluorimetric assay for brain monoamine oxidasePublished by Elsevier ,2002
- Effects of subchronic nicotine administration on central dopaminergic mechanisms in the ratNeurochemical Research, 1989
- Platelet monoamine oxidase: Low activity in cigarette smokersPsychiatry Research, 1987
- Exposure to cigarette smoke does not decrease the neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in miceNeuroscience Letters, 1987
- Cigarette smoking and Parkinson's diseaseNeurology, 1986
- The effect of cigarette smoking on 7‐ethoxyresorufin O‐deethylase and other monooxygenase activities in human liver: analyses with monoclonal antibodies.British Journal of Clinical Pharmacology, 1986
- Increases in dopamine utilization in certain limbic dopamine terminal populations after a short period of intermittent exposure of male rats to cigarette smokeJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1986
- Simultaneous mainstream-sidestream smoke exposure systems II. The rat exposure systemToxicology, 1985
- AETIOLOGY OF PARKINSON'S DISEASEThe Lancet, 1983